Refarmed Chemicals is proud to present its esteemed pharmaceutical compound, Butamirate Citrate, an integral antitussive agent designed to alleviate discomfort in patients suffering from dry, unproductive coughs. Our Butamirate Citrate is an optimal choice for those grappling with upper respiratory tract infections, bronchitis, pneumonia, and even asthma, providing relief from persistent coughing that often accompanies these conditions. Crafted with meticulous attention to quality, our Butamirate Citrate appears as a white to yellowish powder with a slightly waxy texture, assuring ease of incorporation into various dosage forms. Its chemical identity is confirmed through rigorous testing, including the citrate and IR tests, maintaining a high level of purity and performance. The compound exhibits excellent solubility, being freely soluble in water and ethanol (96%), which ensures flexibility in formulation. Adhering to the gold standard of production, Butamirate Citrate holds GMP certification and is characterized by a precise pH range of 3.5 to 4.0. Our commitment to safety and efficacy is evidenced by the thorough analysis that guarantees an assay value between 98.0% - 102.0%, with minimal impurities. Heavy metals content is strictly controlled to ensure patient safety, and residual solvents such as Isopropanol, MTBE, Isopropyl ether, and Toluene are meticulously regulated. Our Butamirate Citrate operates by targeting the cough center in the medulla oblongata to effectively suppress cough reflexes, without reliance on opioids. This action provides a duration of relief for 4-8 hours, allowing for a more comfortable recovery process for the patient. It is suitable for adults and children over the age of 6, with dosage adjustments available to accommodate individual patient responses and tolerability. In conclusion, Refarmed Chemicals' Butamirate Citrate stands as a testament to our dedication to delivering pharmaceutical ingredients of the highest caliber. Our product not only meets the robust demands of the pharmaceutical industry but also provides a critical component for the formulation of efficacious cough suppressants that cater to a wide range of patients.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Benserazide Hydrochloride, offered under REFARMED CHEMICALS—a subsidiary of the DKSH Group—is an essential pharmaceutical ingredient tailored for the robust demands of the medical industry. Specifically formulated for the management of Parkinson’s disease, Benserazide Hydrochloride serves as a monoamine oxidase B (MAO-B) inhibitor. When synergistically combined with levodopa, it not only amplifies the efficacy of the treatment but also mitigates associated side effects such as nausea, enhancing the quality of life for patients suffering from this neurodegenerative condition. Our Benserazide Hydrochloride emerges as a white to off-white crystalline powder, a testament to its purity and quality. The compound exhibits admirable water solubility, ensuring ease of formulation and bioavailability. Its molecular identity, C10H14N2O3·HCl, with a molecular weight of 234.7 g/mol, aligns with rigorous pharmaceutical prerequisites. Our product delivers through a strict adherence to quality with an assay value ranging from 98.5% to 101.0%, guaranteeing a high-caliber substance with minimal impurity content. REFARMED CHEMICALS prioritizes safety and compliance, validating Benserazide Hydrochloride's authenticity with the IR and Chlorides test among others, and acknowledges the product’s conscientious solubility in water and minimal solubility in anhydrous ethanol. We maintain stringent control on residual solvents, ensuring ethanol levels remain below 5000 ppm and methanol below 3000 ppm. Administered orally, this pharmaceutical agent's dosage is contingent upon individual patient needs and medical recommendations, subject to professional healthcare guidance. Despite its profound benefits, it should be noted that Benserazide Hydrochloride is contraindicated for patients with severe hepatic or renal impairments and requires cautious use in patients with a history of cardiovascular diseases, orthostatic hypotension, or psychiatric conditions. Interaction with opioids and antidepressants necessitates careful management. Upholding the highest standards, our product is compliant with Good Manufacturing Practice (GMP) and holds the Certificate of Suitability (CEP)—a rigorous certification ensuring consistency in high-quality production for our corporate customers. With REFARMED CHEMICALS, you are guaranteed a product that not only addresses the therapeutic needs but also embodies the precision and reliability sought after in the pharmaceutical industry.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Refarmed Chemicals takes pride in offering pharmaceutical-grade Ciclopirox Olamine, an indispensable antifungal agent in the medical field. Specifically targeting fungal infections such as athlete's foot (tinea pedis), jock itch (tinea cruris), ringworm (tinea corporis), and various Candida (yeast) infections, our product showcases a versatile application in creating topical treatments like creams and lotions as well as oral medications and veterinary solutions. Engineered for effectiveness, our Ciclopirox Olamine guarantees a high purity level of 76.0 - 78.5%, ensuring a potent defense against a wide-ranging spectrum of fungal strains. With a broad-spectrum antifungal profile, it is noted for its remarkable efficacy and minimum side effects, making it a well-tolerated choice for patients. This pharmaceutical agent comes in a white to pale yellow crystalline powder form, demonstrating superb solubility in water, alcohol, and chloroform. The CAS number associated with this compound is 41623-74-0, a testament to its consistent and recognized chemical identity. The provided product satisfies rigorous quality checks, with specifications like pH values of 8.0 - 9.0, heavy metals content below 20 ppm, loss on drying under 1.5%, and a sulfated ash content not exceeding 0.1%. Administered typically in a twice-daily regimen, the antifungal should be applied with caution, avoiding use by individuals with known allergies to the compound as well as contact with open wounds or broken skin. To ensure optimal results and patient safety, any occurrence of skin irritation should prompt immediate consultation with healthcare professionals. Presented in a concise yet comprehensive datasheet, our Ciclopirox Olamine is a testament to Refarmed Chemicals' dedication to the advancement of pharmaceutical care, offering a high-quality solution for antifungal needs. The described product is a vital component in the armamentarium against challenging fungal infections, bolstering our commitment to delivering growth in the industry and beyond.

Products still subject to third-party patent protection might be available solely for R&D purposes.